Top Markets
#1 Black Phoenix Black Phoenix +875.00%
#2 Nesa Nesa +436.99%
#3 MetaDAO MetaDAO +30.34%
#4 Stacks Stacks +21.32%
#5 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +21.22%
#6 Ontology Gas Ontology Gas +20.19%
#7 Purr Purr +19.55%
#8 Bedrock Bedrock +19.51%
#9 Cash Cat Cash Cat +15.35%
#10 Pons Pons +14.87%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Abiomed, Inc. Abiomed, Inc.

Abiomed, Inc.

ABMD
Classifica tra le azioni #1388
Abiomed, Inc. specializes in the creation and distribution of advanced medical... Abiomed, Inc. specializes in the creation and distribution of advanced medical technology designed to support or substitute the heart's pumping action in patients suffering from heart failure, while also offering ongoing care for these individuals. Its product portfolio includes various devices from the Impella family. The Impella 2.5 is a tiny percutaneous heart pump featuring an integrated motor and sensors, alongside the Impella CP, which is utilized by interventional cardiologists in catheterization labs and by cardiac surgeons during operations. Other Impella models such as the 5.0, LD, and 5.5 are also percutaneous micro heart pumps, primarily employed in surgical settings. The Impella RP is a percutaneous catheter-based axial flow pump. Beyond the pumps, Abiomed offers the Impella SmartAssist platform, which leverages optical sensors for precise pump placement and uses algorithms to enhance native heart function assessment during patient weaning. Its Impella Connect system provides secure, cloud-based remote monitoring of the automated Impella controller for medical staff. The company also markets the OXY-1 System, a portable device for external respiratory support. Furthermore, Abiomed is actively developing several innovations, including the Impella ECP pump for high blood flow rates, the Impella XR Sheath for smaller access during Impella procedures, the Impella BTR percutaneous micro heart pump, and preCARDIA, a catheter-based superior vena cava therapy system aimed at quickly addressing acute decompensated heart failure. Abiomed distributes its products globally through its dedicated direct sales and clinical support teams, reaching regions such as the United States, Japan, Canada, countries across Europe (including Germany and France), Latin America, the Asia-Pacific, and the Middle East. Founded in 1981 and headquartered in Danvers, Massachusetts, Abiomed, Inc. has been operating as a subsidiary of Johnson & Johnson since December 22, 2022.
Prezzo delle azioni
$381.02
Ultima sincronizzazione: 2022-12-23
Capitalizzazione di mercato
$17.18B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Abiomed, Inc. (ABMD)

Categoria

Healthcare
Storico dividendi per Abiomed, Inc. (ABMD)
Abiomed, Inc. (simbolo azionario: ABMD) ha effettuato un totale di 0 pagamenti di dividendi.
La somma totale dei dividendi (rettificata per split azionari) è: 0.00
Rendimento da dividendo (TTM): 0
Pagamenti dei dividendi per Abiomed, Inc. (ABMD) dal 2026 al 2026
Pagamenti annuali dei dividendi
Anno Dividendo (rettificato per split azionari) Cambia
Non abbastanza dati per le date fornite.
Elenco di tutti i pagamenti di dividendi
Anno Dividendo Cambia
Non abbastanza dati per le date fornite.
Dividendi di aziende simili o concorrenti
Azienda Numero di pagamenti di dividendi Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
173.00%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
85.00%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
178.00%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
0.00%
DE